Please ensure Javascript is enabled for purposes of website accessibility

What's Behind Castlight Health Rallying 13.2% Today

By Todd Campbell – Updated May 10, 2017 at 4:58PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A filing with the SEC showed a big hedge fund increased its position in the healthcare data analytics company.

What happened

Castlight Health (CSLT) share price climbed 13.2% Wednesday after an SEC filing revealed that Maverick Capital had significantly boosted its stake in the company to 10.6%.

So what

At the end of 2016, Maverick Capital owned 1.19 million shares of Castlight Health; according to Wednesday's filing with the SEC, it now owns over 8.9 million shares, or about 10.6% of the company.

A person stands with arms raised as money falls around him.


The news follows Castlight Health's first-quarter earnings report last month, which showed sales of $27.75 million, up 22% from a year before, and a loss of $0.05 per share that was better than the loss of $0.13 per share reported in Q1 2016.

The company expects to report GAAP revenue between $132 million to $136 million dollars and a non-GAAP loss of between $0.24 to $0.28 per share for 2017. 

Now what

The past few years have been a tough period to be a shareholder in Castlight Health, but Maverick obviously thinks that the company's on the right track to growing its business.

CSLT Chart

CSLT data by YCharts

The healthcare data analytics company uses information provided by  insurers to create healthcare recommendations for patients; the money-saving potential of its services is attractive to both insurers and self-insuring employers hoping to lower their healthcare costs.

Certainly, the prospect of lowering healthcare expenses by providing patients with greater transparency into healthcare prices is an appealing approach, but only time will tell if it can win over enough clients for Castlight to turn a profit, and for Maverick Capital to be rewarded for being a buyer.

Todd Campbell has no position in any stocks mentioned. His clients may have positions in the companies mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Castlight Health Stock Quote
Castlight Health

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.